Results 11 to 20 of about 6,242,441 (357)

Drugging Drug Resistance [PDF]

Cell, 2010
Resistance to anticancer drugs is widely observed in vitro and in cancer patients, but its prevalence is too high to be solely explained by the acquisition of mutations. Sharma et al. (2010) now report that dynamic chromatin modifications may be an independent route to drug resistance in cancer cells that can be reversed by epigenetic drugs.
Dannenberg, Jan-Hermen, Berns, Anton
openaire   +2 more sources

NOACs: drug–drug interactions [PDF]

Canadian Medical Association Journal, 2016
We commend Fralick and colleagues for their article on drug interactions with rivaroxaban.[1][1] All novel oral anticoagulants (NOACs) were introduced as at least noninferior (in some cases superior) to warfarin.
Bartosz, Hudzik, Andrzej, Lekston, Mariusz, Gasior   +2 more
openaire   +2 more sources

Doctor or drug dealer? International legal provisions for the legitimate handling of drugs of abuse [PDF]

, 2020
© The Author(s) 2020. The final, definitive version of this paper has been published in: Gallagher, C. T., Atik, S. K., Isse, L., & Mann, S. K. (2020). Doctor or drug dealer?
Atik, Sanaa, Gallagher, Cathal, Isse, Libin, Mann, Sanpreet   +3 more
core   +2 more sources

Pharmacogenetics of analgesic drugs [PDF]

, 2013
• Individual variability in pain perception and differences in the efficacy of analgesic drugs are complex phenomena and are partly genetically predetermined.
Branford, R, Cregg, R, Gubbay, A, Russo, G, Sato, H   +4 more
core   +1 more source

Orphan drugs and the NHS: Should we value rarity [PDF]

, 2005
Cost effectiveness plays an important part in current decisions about the funding of health technologies. Drugs for rare disease (orphan drugs) are often expensive to produce and, by definition, will benefit only small numbers of patients.
Claxton, K., McCabe, C., Tsuchiya, A.
core   +2 more sources

Entry in the ADHD drugs market: Welfare impact of generics and me-toos [PDF]

, 2013
Recent decades have seen a growth in treatments for attention deficit hyperactivity disorder (ADHD) including many branded and generic drugs. In the early 2000's, new drug entry dramatically altered market shares.
Angell M., Barkley R. A., Bulow J., Conner D. F., Deaton A., FDAnews Drug Daily Bulletin, Frank R. G., Goozner M., Hausman J. A., Hausman J. A., Perwien A. R., Rector T. S., Safer D. J., Shulman S. R., Spencer T. J.   +14 more
core   +1 more source

Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB. [PDF]

, 2016
Repurposing has gained momentum globally and become an alternative avenue for drug discovery because of its better success rate, and reduced cost, time and issues related to safety than the conventional drug discovery process.
Brindha, Sridharan, Gnanadoss, John Joel, Sundaramurthi, Jagadish Chandrabose, Velmurugan, Devadasan, Vincent, Savariar   +4 more
core   +1 more source

Physical and Chemical Properties and Quality Control Methods of Hyaluronic Acid (Review)

Разработка и регистрация лекарственных средств, 2020
Introduction. This review describes the physicochemical properties that determine the use of hyaluronic acid in ophthalmology. We have studied methods for determining hyaluronic acid using various analytical methods.Text.
A. Kh. Amandusova, K. R. Saveleva, A. V. Morozov, V. A. Shelekhova, L. V. Persanova, S. V. Polyakov, V. N. Shestakov   +6 more
doaj   +1 more source

Acknowledgement to Reviewers of Marine Drugs in 2016

Marine Drugs, 2017
The editors of Marine Drugs would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016. [...]
Marine Drugs Editorial Office
doaj   +1 more source

Acknowledgement to Reviewers of Marine Drugs in 2018

Marine Drugs, 2019
Rigorous peer-review is the corner-stone of high-quality academic publishing [...]
Marine Drugs Editorial Office
doaj   +1 more source